Stock listing

Frankfurt:E08A Exagen Inc. Aktie

German listing (Frankfurt) of Exagen Inc. · home listing NASDAQ:XGN

Follow Exagen Inc. into a list and get an email when it puts out news.

Share price · FWB:E08A

€3.38 EUR -0.16 (-4.5%)

Close on Nov 20, 2026

Past year -34.5% · daily closes, Nov 20, 2025 – Nov 12, 2026, adjusted for splits
Day range
€3.38 – €3.38 EURNov 20, 2026
Market cap
€81.88M EURAt the close on Nov 20, 2026 · price × 24.23M shares outstanding
52-week range
€2.27 – €7.57 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€492 EURMedian day 0 shares · 52 days with no trades · last 3 months, Aug 20, 2026 – Nov 12, 2026
Exagen Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:XGN · Home$3.61 USD-0.29 (-7.4%)508,828$3.765$3.90$3.48$3.90Close on Nov 20, 2026
Frankfurt:E08A€3.38 EUR-0.16 (-4.5%)—€3.38€3.38€3.38€3.54Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 12, 2026 · FWB:E08A · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€4.425-0.384-8.0%€4.425€4.425€4.4250
€4.809-1.419-22.8%€4.809€4.809€4.8090
€6.228+1.092+21.3%€6.228€6.228€6.2281,600
€5.136-1.552-23.2%€5.136€5.136€5.1360
€6.688-0.67-9.1%€6.688€6.688€6.6880
€7.358+0.031+0.4%€7.358€7.358€7.3580
€7.327-0.014-0.2%€7.327€7.327€7.3270
€7.341-0.227-3.0%€7.341€7.341€7.3410
€7.568+0.028+0.4%€7.568€7.568€7.5680
€7.54+0.233+3.2%€7.54€7.54€7.54126
€7.307+0.37+5.3%€7.307€7.307€7.3070
€6.937+0.335+5.1%€6.937€6.937€6.937222
€6.602+0.188+2.9%€6.602€6.602€6.6020
€6.414-0.137-2.1%€6.414€6.414€6.4140
€6.551-0.285-4.2%€6.551€6.551€6.5510
€6.836+0.338+5.2%€6.836€6.836€6.8360
€6.498-0.0020.0%€6.498€6.498€6.4980
€6.50-0.328-4.8%€6.50€6.50€6.50111
€6.828-0.68-9.1%€6.828€6.828€6.8280
€7.508+0.175+2.4%€7.508€7.508€7.5080
€7.333-0.097-1.3%€7.333€7.333€7.3330
€7.43+0.19+2.6%€7.43€7.43€7.430
€7.24-0.156-2.1%€7.24€7.24€7.240
€7.396+0.278+3.9%€7.396€7.396€7.3960
€7.118-0.133-1.8%€7.118€7.118€7.1180
€7.251+0.139+2.0%€7.251€7.251€7.2510
€7.112-0.281-3.8%€7.112€7.112€7.1120
€7.393+0.214+3.0%€7.393€7.393€7.393394
€7.179+0.262+3.8%€7.179€7.179€7.1790
€6.917-0.215-3.0%€6.917€6.917€6.9170
€7.132-0.071-1.0%€7.132€7.132€7.1320
€7.203-0.137-1.9%€7.203€7.203€7.2030
€7.34-0.138-1.8%€7.34€7.34€7.340
€7.478-0.074-1.0%€7.478€7.478€7.4780
€7.552+0.158+2.1%€7.552€7.552€7.552619
€7.394-0.067-0.9%€7.394€7.394€7.3940
€7.461+0.094+1.3%€7.461€7.461€7.4610
€7.367+0.078+1.1%€7.367€7.367€7.3670
€7.289+0.59+8.8%€7.289€7.289€7.2890
€6.699-0.016-0.2%€6.699€6.699€6.6990
€6.715+0.302+4.7%€6.715€6.715€6.7150
€6.413+0.20+3.2%€6.413€6.413€6.4130
€6.213+0.314+5.3%€6.213€6.213€6.2130
€5.899+0.019+0.3%€5.899€5.899€5.8990
€5.88-0.312-5.0%€5.88€5.88€5.88990
€6.192+0.051+0.8%€6.192€6.192€6.1920
€6.141-0.204-3.2%€6.141€6.141€6.1410
€6.345-0.053-0.8%€6.345€6.345€6.345270
€6.398+0.063+1.0%€6.398€6.398€6.3980
€6.335+0.016+0.3%€6.335€6.335€6.335270
€6.319+0.34+5.7%€6.319€6.319€6.3190
€5.979-0.211-3.4%€5.979€5.979€5.9790
€6.19-0.028-0.5%€6.19€6.19€6.190
€6.218-0.101-1.6%€6.218€6.218€6.2180
€6.319-0.188-2.9%€6.319€6.319€6.3190
€6.507+0.12+1.9%€6.507€6.507€6.5070
€6.387-0.029-0.5%€6.387€6.387€6.3870
€6.416-0.219-3.3%€6.416€6.416€6.4160
€6.635+0.097+1.5%€6.635€6.635€6.6350
€6.538+0.291+4.7%€6.538€6.538€6.5380
€6.247+0.691+12.4%€6.247€6.247€6.2470
Ticker
Frankfurt:E08A
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Exagen (NASDAQ:XGN) Q3 2026 Earnings Call

    Tue, Nov 10, 2026 · 8:00 AM ET

    Watch Transcript
  • Exagen (NASDAQ:XGN) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 8:30 AM ET

    Watch Transcript
  • Exagen (NASDAQ:XGN) Q1 2026 Earnings Call

    Mon, May 11, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

All Exagen Inc. news

Financings

  • Public offering of common stock

    May 9, 2025

    Closed: US$17.59M raised · US$5.25 a share · Canaccord Genuity

    Dealers: Canaccord Genuity (lead)

    Announced May 7, 2025 · Update May 8, 2025 · Closed May 9, 2025

  • Senior secured term loans with warrants

    Apr 28, 2025

    Tranche closed: US$25M raised · warrant to purchase 400,000 shares of common stock: 200,000 exercisable at $4.96 per… · Credo 180, Inc.

    Dealers: Credo 180, Inc.

    Buyers: Perceptive Advisors LLC (term loans of up to $75 million, $25 million funded at close, plus warrants to purchase 400,000 shares)

    Use of proceeds: Retire the existing term debt facility with Innovatus Capital Partners and strengthen the balance sheet

    Tranche closed Apr 28, 2025

Read by 6ix AI from the company's releases

Decks

Exagen Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
14 in the last 12 months · 146 in all · newest Nov 10, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 10, 2026
Decks
7 decks · latest Nov 10, 2026

Where Exagen Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:XGN · Home listingNASDAQUnited StatesUSD
BOATS:XGNBOATSUnited StatesUSD
gettex:E08AgettexGermanyEUR
LS Exchange:A2PRXTLS ExchangeGermanyEUR
Lang & Schwarz:A2PRXTLang & SchwarzGermanyEUR
Dusseldorf:E08ADusseldorfGermanyEUR
Frankfurt:E08A · This pageFrankfurtGermanyEUR
Munich:E08AMunichGermanyEUR
Stuttgart:E08AStuttgartGermanyEUR
Tradegate:E08ATradegateGermanyEUR

Log in to ask 6ix AI your own questions about Exagen Inc.